TY - JOUR
T1 - Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product
AU - Uddin, S.
AU - Yetter, A.
AU - Katzav, S.
AU - Hofmann, C.
AU - White, M. F.
AU - Platanias, L. C.
PY - 1996
Y1 - 1996
N2 - The vav proto-oncogene product (p95(vav) is specifically expressed in cells of hematopoietic origin and has one src homology 2 (SH2) domain, two SH3 domains, and motifs typical of guanine exchange factors. Insulin-like growth factor-1 (IGF-1) receptors are expressed on a variety of hematopoietic cells and, upon ligand binding, mediate signals regulating hematopoietic cell proliferation. We studied the phosphorylation status of p95(vav) in the U-266 human myeloma cell line, in response to IGF-1 stimulation. Immunoblotting experiments with an antiphosphotyrosine monoclonal antibody disclosed that p95(vav) is phosphorylated on tyrosine in an IGF-1-dependent manner. The tyrosine phosphorylation of p95(vav) was rapid, appearing within 5 minutes of IGF-1 treatment, and transient, diminishing by 90 minutes. Similar results were obtained when the mouse plasmacytoma J558L cell line was studied. IGF-1-dependent tyrosine phosphorylation of p95(vav) was also seen in the 32D mouse myeloid cell line that lacks expression of insulin receptor substrate (IRS) proteins, suggesting that it is not regulated by activation of the IRS-signaling system. Taken together, these data suggest that the vav proto-oncogene is a substrate for the IGF-1 receptor tyrosine kinase and may be involved in the signal transduction of IGF-1 in cells of hematopoietic origin.
AB - The vav proto-oncogene product (p95(vav) is specifically expressed in cells of hematopoietic origin and has one src homology 2 (SH2) domain, two SH3 domains, and motifs typical of guanine exchange factors. Insulin-like growth factor-1 (IGF-1) receptors are expressed on a variety of hematopoietic cells and, upon ligand binding, mediate signals regulating hematopoietic cell proliferation. We studied the phosphorylation status of p95(vav) in the U-266 human myeloma cell line, in response to IGF-1 stimulation. Immunoblotting experiments with an antiphosphotyrosine monoclonal antibody disclosed that p95(vav) is phosphorylated on tyrosine in an IGF-1-dependent manner. The tyrosine phosphorylation of p95(vav) was rapid, appearing within 5 minutes of IGF-1 treatment, and transient, diminishing by 90 minutes. Similar results were obtained when the mouse plasmacytoma J558L cell line was studied. IGF-1-dependent tyrosine phosphorylation of p95(vav) was also seen in the 32D mouse myeloid cell line that lacks expression of insulin receptor substrate (IRS) proteins, suggesting that it is not regulated by activation of the IRS-signaling system. Taken together, these data suggest that the vav proto-oncogene is a substrate for the IGF-1 receptor tyrosine kinase and may be involved in the signal transduction of IGF-1 in cells of hematopoietic origin.
KW - Insulin-like growth factor-1
KW - Tyrosine phosphorylation
KW - vav proto-oncogene
UR - http://www.scopus.com/inward/record.url?scp=0029926095&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 8605967
AN - SCOPUS:0029926095
SN - 0301-472X
VL - 24
SP - 622
EP - 627
JO - Experimental Hematology
JF - Experimental Hematology
IS - 5
ER -